Ensysce Biosciences Inc. Warrants(ENSCW)

Description: Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. The company is developing tamper-proof opioids using Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms. Its products treat severe pain and assist in preventing deaths caused by opioid abuse. The company is based in La Jolla, California.

Keywords: Drugs Pain Euphoriants Psychoactive Drugs Opioids Morphinans Heroin Morphine Opioid Use Disorder Substance Dependence Opioid Epidemic In The United States

Home Page:

ENSCW Technical Analysis

7946 Ivanhoe Avenue
La Jolla, CA 92037
United States
Phone: 858-263-4196


Name Title
Dr. D. Lynn Kirkpatrick CEO & Director
Mr. David C. Humphrey Chief Financial Officer
Dr. Jeffrey Millard Chief Operating Officer
Mr. Richard Wright M.B.A., MSE Chief Bus. Officer
Mr. Geoff Birkett Chief Commercial Officer
Dr. William K. Schmidt Chief Medical Officer

Exchange: PINK

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 0
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks